{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:05:29Z","timestamp":1777871129145,"version":"3.51.4"},"reference-count":6,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jaad.2025.01.010","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T19:20:01Z","timestamp":1737141601000},"page":"1227-1228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Letter from the editor: Advances in testing for autoimmune bullous diseases"],"prefix":"10.1016","volume":"92","author":[{"given":"Dirk M.","family":"Elston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jaad.2025.01.010_bib1","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/jamadermatol.2021.1036","article-title":"Assessment of diagnostic strategy for mucous membrane pemphigoid","volume":"157","author":"Rashid","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2025.01.010_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/cup.14176","article-title":"Impact of adding an IgG4 conjugate to routine direct immunofluorescence testing for subepithelial and intraepithelial autoimmune blistering disorders","volume":"49","author":"Lehman","year":"2022","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2025.01.010_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1464881","article-title":"Quality-controlled characterization of a monoclonal antibody specific to an EC5-domain of human desmoglein 3 for pemphigus research","volume":"15","author":"Eming","year":"2024","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.jaad.2025.01.010_bib4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/1346-8138.17175","article-title":"Low pH condition impairs BP-IgG binding to the basement membrane zone","volume":"51","author":"Im","year":"2024","journal-title":"J Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2025.01.010_bib5","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1515\/cclm-2019-1031","article-title":"Detection of circulating anti-skin antibodies by indirect immunofluorescence and by ELISA: a comparative systematic review and meta-analysis","volume":"58","author":"Van de Gaer","year":"2020","journal-title":"Clin Chem Lab Med"},{"issue":"9","key":"10.1016\/j.jaad.2025.01.010_bib6","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.5858\/arpa.2023-0274-OA","article-title":"C3d immunohistochemical staining on paraffin-embedded tissue for diagnosis of pemphigus","volume":"148","author":"Wu","year":"2024","journal-title":"Arch Pathol Lab Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225000490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225000490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T17:02:17Z","timestamp":1777568537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225000490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":6,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0190962225000490"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.01.010","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Letter from the editor: Advances in testing for autoimmune bullous diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2024.10.120","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}